Denitine 150 mg (Tablet)

Unit Price: ৳ 2.00 (100's pack: ৳ 200.00)

Medicine Details

Title

  • Denitine Tablet & Syrup

Categories

  • Gastrointestinal Medication
  • Ulcer Treatment
  • Acid Reducer
  • Reflux Relief

Description

  • Denitine is indicated for the treatment of active duodenal ulcer, benign gastric ulcer, ulcer associated with non-steroidal anti-inflammatory agents, post-operative stress ulcer, Zollinger-Ellison Syndrome, GERD, gastrointestinal hemorrhage, recurrent hemorrhage, and prevention of acid aspiration before general anesthesia.

DosageForm

  • Tablet
  • Syrup
  • IV Injection
  • IV Infusion

DosageAdministration

  • Usual dosage for duodenal and gastric ulcer is 150 mg twice daily for 4 to 8 weeks
  • For reflux esophagitis: 150 mg twice daily for up to 8 weeks
  • For Zollinger Ellison syndrome: 150 mg 3 times daily, increased if necessary
  • Episodic dyspepsia: 150 mg twice daily for up to 6 weeks
  • Maintenance: 150 mg at night for preventing recurrences
  • For children (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily
  • IV Injection & IV Infusion: Specific dosages based on condition and patient type

Pharmacology

  • Competitively blocks histamine at H2-receptors of the gastric parietal cells which inhibits gastric acid secretion
  • Does not affect pepsin secretion, pentagastrin-stimulated intrinsic factor secretion or serum gastrin

Interaction

  • Delayed absorption and increased peak serum concentration with propantheline bromide
  • Minimally inhibits hepatic metabolism of certain drugs
  • May alter absorption of pH-dependent drugs, reduce bioavailability with antacids

Contraindications

  • Hypersensitivity to Ranitidine

SideEffects

  • Altered bowel habit
  • Dizziness
  • Rash
  • Tiredness
  • Reversible confusional states
  • Headache
  • Decreased blood counts
  • Muscle or joint pain

PregnancyLactation

  • Crosses placenta with no evidence of impaired fertility or harm to the fetus
  • Excreted in human breast milk, caution advised during lactation

SpecialPopulation

  • Reduced dosage for patients with impaired renal and hepatic function
  • Similar ulcer healing rates in elderly patients as in younger patients

Overdose

  • Specific in action, no particular problems expected following overdosage
  • Symptomatic and supportive therapy recommended if overdosage occurs
  • Haemodialysis may be used if necessary

TherapeuticClass

  • H2 Receptor Antagonist

Reconstitution

  • Specific reconstitution guidelines for slow IV injection, intermittent slow IV infusion, and continuous IV infusion

StorageConditions

  • Store in a cool and dry place, protect from light

Related Brands